Curative Biotechnology, Inc. (OTCMKTS:CUBT) Sees Significant Increase in Short Interest

Curative Biotechnology, Inc. (OTCMKTS:CUBT) saw a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 19,400 shares, a growth of 487.9% from the March 31st total of 3,300 shares. Based on an average daily volume of 678,300 shares, the days-to-cover ratio is presently 0.0 days.

Curative Biotechnology Price Performance

CUBT remained flat at $0.03 during trading hours on Thursday. The company had a trading volume of 76,000 shares, compared to its average volume of 241,563. The business’s fifty day moving average is $0.03 and its 200-day moving average is $0.02. Curative Biotechnology has a 12-month low of $0.01 and a 12-month high of $0.04.

About Curative Biotechnology

Curative Biotechnology, Inc, a development-stage biomedical company, focuses on novel treatments for rare diseases. The company focuses on therapies with potentially accelerated development paths as a result of the disease, the nature of the therapeutic itself, or the stage of clinical development. Its pipeline candidates include CURB906, an antibody-drug conjugate for targeting CD56 positive brain tumors; and IMT504, a novel immune therapy to treat rabies.